Approximately 85% of MG patients have autoantibodies against the acetylcholine receptor (AChR), and a small proportion of patients have antibodies against muscle-specific tyrosine kinase (MuSK) (Lazaridis and Tzartos, 2020). This evidence concerns the gene MUSK and myasthenia gravis.